- Zacks•22 hours ago
On Mar 20, we issued an updated research report on Redwood City, CA-based Genomic Health Inc. (GHDX), a leading global cancer company with a focus on advanced molecular diagnostics.
Genomic Health (GHDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks•2 days ago
Genomic Health, Inc. (GHDX), a leading molecular diagnostics company, recently presented results from 15 Oncotype DX Breast Recurrence Score studies.
GHDX : Summary for Genomic Health, Inc. - Yahoo Finance
Genomic Health, Inc. (GHDX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||24.30 x 100|
|Day's Range||30.62 - 31.10|
|52 Week Range||22.45 - 33.96|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-73.69|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|